204 related articles for article (PubMed ID: 33492725)
1. Critical angioedema induced by a renin angiotensin system blocker in the contemporary era of increasing heart failure: A case report and commentary.
Sato M; Takahashi M; Kario K
J Clin Hypertens (Greenwich); 2021 Mar; 23(3):692-695. PubMed ID: 33492725
[TBL] [Abstract][Full Text] [Related]
2. Angioedema related to Angiotensin inhibitors.
Knecht SE; Dunn SP; Macaulay TE
J Pharm Pract; 2014 Oct; 27(5):461-5. PubMed ID: 25124378
[TBL] [Abstract][Full Text] [Related]
3. Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system.
Toh S; Reichman ME; Houstoun M; Ross Southworth M; Ding X; Hernandez AF; Levenson M; Li L; McCloskey C; Shoaibi A; Wu E; Zornberg G; Hennessy S
Arch Intern Med; 2012 Nov; 172(20):1582-9. PubMed ID: 23147456
[TBL] [Abstract][Full Text] [Related]
4. An Overview of Clinically Imperative and Pharmacodynamically Significant Drug Interactions of Renin-Angiotensin-Aldosterone System (RAAS) Blockers.
Mohamed Pakkir Maideen N; Balasubramanian R; Muthusamy S; Nallasamy V
Curr Cardiol Rev; 2022; 18(6):e110522204611. PubMed ID: 35546745
[TBL] [Abstract][Full Text] [Related]
5. ACE-Inhibitors in Hypertension: A Historical Perspective and Current Insights.
Cutrell S; Alhomoud IS; Mehta A; Talasaz AH; Van Tassell B; Dixon DL
Curr Hypertens Rep; 2023 Sep; 25(9):243-250. PubMed ID: 37284934
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin-Converting Enzyme Inhibitors in Hypertension: To Use or Not to Use?
Messerli FH; Bangalore S; Bavishi C; Rimoldi SF
J Am Coll Cardiol; 2018 Apr; 71(13):1474-1482. PubMed ID: 29598869
[TBL] [Abstract][Full Text] [Related]
7. Combined angiotensin receptor/neprilysin inhibitors: a review of the new paradigm in the management of chronic heart failure.
Macdonald PS
Clin Ther; 2015 Oct; 37(10):2199-205. PubMed ID: 26386501
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II receptor blocker-associated angioedema: on the heels of ACE inhibitor angioedema.
Abdi R; Dong VM; Lee CJ; Ntoso KA
Pharmacotherapy; 2002 Sep; 22(9):1173-5. PubMed ID: 12222553
[TBL] [Abstract][Full Text] [Related]
9. Renin angiotensin system blockers-associated angioedema in the Thai population: analysis from Thai National Pharmacovigilance Database.
Win TS; Chaiyakunapruk N; Suwankesawong W; Dilokthornsakul P; Nathisuwan S
Asian Pac J Allergy Immunol; 2015 Sep; 33(3):227-35. PubMed ID: 26342120
[TBL] [Abstract][Full Text] [Related]
10. A Rare Case of Losartan-Induced Visceral Angioedema.
Rosas S; Fowler A; Stodgill E; Deyo-Svendsen M; Phillips M
J Prim Care Community Health; 2023; 14():21501319231213744. PubMed ID: 37965705
[TBL] [Abstract][Full Text] [Related]
11. Angioedema in heart failure: occurrence with ACE inhibitors and safety of angiotensin receptor blocker therapy.
Sica DA; Black HR
Congest Heart Fail; 2002; 8(6):334-41, 345. PubMed ID: 12461324
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting enzyme inhibitor-induced angioedema: A review of the literature.
Brown T; Gonzalez J; Monteleone C
J Clin Hypertens (Greenwich); 2017 Dec; 19(12):1377-1382. PubMed ID: 28994183
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II receptor blockers in patients with ACE inhibitor-induced angioedema.
Warner KK; Visconti JA; Tschampel MM
Ann Pharmacother; 2000 Apr; 34(4):526-8. PubMed ID: 10772441
[TBL] [Abstract][Full Text] [Related]
14. Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition.
Hubers SA; Brown NJ
Circulation; 2016 Mar; 133(11):1115-24. PubMed ID: 26976916
[TBL] [Abstract][Full Text] [Related]
15. Current concepts of pharmacotherapy in hypertension: ACE inhibitor-related angioedema: can angiotensin-receptor blockers be safely used?
Sica DA; Black HR
J Clin Hypertens (Greenwich); 2002; 4(5):375-80. PubMed ID: 12368584
[TBL] [Abstract][Full Text] [Related]
16. Treatment of angiotensin receptor blocker-induced angioedema: A case series.
Strassen U; Bas M; Hoffmann TK; Knopf A; Greve J
Laryngoscope; 2015 Jul; 125(7):1619-23. PubMed ID: 25646708
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
18. The impact of age and sex on the reporting of cough and angioedema with renin-angiotensin system inhibitors: a case/noncase study in VigiBase.
Alharbi FF; Kholod AAV; Souverein PC; Meyboom RH; de Groot MCH; de Boer A; Klungel OH
Fundam Clin Pharmacol; 2017 Dec; 31(6):676-684. PubMed ID: 28767167
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin Receptor-Neprilysin Inhibition Based on History of Heart Failure and Use of Renin-Angiotensin System Antagonists.
Ambrosy AP; Braunwald E; Morrow DA; DeVore AD; McCague K; Meng X; Duffy CI; Rocha R; Velazquez EJ;
J Am Coll Cardiol; 2020 Sep; 76(9):1034-1048. PubMed ID: 32854838
[TBL] [Abstract][Full Text] [Related]
20. Angioedema in heart failure patients treated with sacubitril/valsartan (LCZ696) or enalapril in the PARADIGM-HF study.
Shi V; Senni M; Streefkerk H; Modgill V; Zhou W; Kaplan A
Int J Cardiol; 2018 Aug; 264():118-123. PubMed ID: 29776559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
